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Abstract
We investigated the protective role of myricetin bulk and nanoforms, against reactive oxygen species (ROS)-induced oxida-
tive stress caused by hydrogen peroxide and tertiary-butyl hydro peroxide in lymphocytes in vitro from healthy individuals 
and those from pre-cancerous patients suffering with monoclonal gammopathy of undetermined significance (MGUS). 
The change in intracellular reactive oxygen species was measured once cells were treated with myricetin bulk forms and 
nanoforms with and without either hydrogen peroxide or tertiary-butyl hydro peroxide co-supplementation. The direct and 
indirect antioxidant activity of myricetin was spectrofluometrically measured using the fluorescent dye 2′,7′-dichlorofluo-
rescin diacetate and using the Comet assay, respectively. Hydrogen peroxide (50 µM) and tertiary-butyl hydro peroxide 
(300 µM) induced a higher level of reactive oxygen species-related DNA damage and strand breaks. Addition of myricetin 
nanoform (20 µM) and bulk (10 µM) form could, however, significantly prevent hydrogen peroxide- and tertiary-butyl hydro 
peroxide-induced oxidative imbalances and the nanoform was more effective. Glutathione levels were also quantified using 
a non-fluorescent dye. Results suggest that myricetin treatment had no significant effect on the cellular antioxidant enzyme, 
glutathione. The current study also investigates the effect of myricetin on the induction of double-strand breaks by staining 
the gamma-H2AX foci immunocytochemically. It was observed that myricetin does not induce double-strand breaks at basal 
levels rather demonstrated a protective effect.
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Introduction
Oxidative stress is a major factor contributing towards the 
development of various illnesses and it is a key inducer of 
cellular lesions. It is triggered by a disparity between the 
production of reactive oxygen species (ROS) and the capac-
ity of biological system to cleanse the reactive intermediates. 
ROS have been shown to induce proliferation in tumour cells 
and mediate the proliferation initiated by epidermal growth 
factor (EGF) or platelet-derived growth factor (PDGF) 
(Burdick et al. 2003; Chao-Wei Chen et al. 2004). Thus, 
antioxidants show an effective preventative effect against 
cancer development by reducing the ROS levels and inhibit-
ing their production. In addition, intracellular ROS produc-
tion has been associated with the mediation of the effects 
caused by anti-cancer drugs like taxol (Perkins et al. 2000; 
Varbiro et al. 2001). Hence data suggests a two-sided role of 
ROS. It has been suggested that cellular redox potential may 
be regulated through increasing glutathione (GSH) pools to 
the mitochondria, hence, preventing ROS formation and cel-
lular injury caused by oxidative stress (Slikker et al. 2001).
Oxidative stress produced by tertiary-butyl hydro perox-
ide (TBHP) and hydrogen peroxide  (H2O2) is well docu-
mented. TBHP is a toxic compound and causes extreme 
discomfort to various organs and systems (Zavodnik et al. 
1988; Sarkar and Sil 2010; Bhattacharya et al. 2011). Expo-
sure of cellular components to TBHP results in an increase 
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of membrane permeability along with hyperpolarization. 
Reaction of TBHP with haemoglobin forms t-butoxyl radi-
cals, which then initiate peroxidation by interacting with 
membrane lipids (Deuticke et al. 1987). Extensive lipid 
peroxidation leads to membrane disturbance (Benatti et al. 
1982). Cellular antioxidant enzymes, like glutathione and 
l-ascorbate, to some level inhibit membrane disruption by 
scavenging the t-butoxyl radicals.
Myricetin (3,5,7,3′,4′,5′-hexahydroxyflavone), an impor-
tant flavonol, is widely found in berries, fruit, and vege-
tables (Wang et al. 2010). A large body of data has been 
published regarding the antioxidant potential of myricetin, 
leaving no doubt that the compound is a strong antioxidant. 
It depicts antioxidant activity by scavenging ROS through 
oxidation of the three hydroxyl groups (3′,4′,5′-position) 
attached in its B ring (Chobot and Hadacek 2011). Sub-
stantial amounts of evidence suggest that myricetin shows 
other promising health beneficiary effects including chemo 
preventative, anti-diabetic, anti-cancer, anti-inflammatory, 
anti-allergic, and activity against cardiovascular diseases 
(Semwal et al. 2016). Studies have demonstrated that the 
physiological concentrations range of myricetin (5–10 µM) 
(Peng and Kuo 2003) could significantly inhibit the produc-
tion of peroxynitrite-induced double-strand breaks (DSBs) 
(Chen et al. 2011) and protect against the oxidative damage 
caused in neurodegenerative disorders (Laabich et al. 2007; 
Shimmyo et al. 2008). Myricetin has been demonstrated to 
prevent the TBHP-induced chemiluminescence of mouse 
liver homogenates (Fraga et al. 1987) and oxidative stress in 
erythrocytes from Type-2 diabetic patients in vitro (Pandey 
et al. 2009).  H2O2-induced oxidative stress and DNA strand 
breaks caused in human lymphocytes and human colonocyte 
cells have been demonstrated and shown to be reduced upon 
myricetin treatment (Dutie et al. 1997).
Although myricetin is a well-established antioxidant, 
little is known about its beneficial role in countering the 
TBHP-induced cytotoxicity in primary lymphocytes ex vivo 
in vitro of healthy individuals and monoclonal gammopathy 
of undermined significance (MGUS) patients. MGUS is an 
asymptomatic precursor (pre-cancerous) condition of mul-
tiple myeloma (MM) and it is well documented that almost 
every case of MM is headed by MGUS (Dhodapkar 2016). 
The aim of the present study was, therefore, to investigate 
the in vitro protective role of myricetin nanoparticles (MYR 
N) and myricetin bulk (MYR B) against TBHP-induced oxi-
dative damage in lymphocytes from healthy individuals and 
MGUS patients. The effect of myricetin nanoforms and bulk 
forms against  H2O2-induced damage, change in intracellular 
ROS due to oxidative stress caused by TBHP and change in 
GSH levels was investigated. The study also assessed the 
effect of myricetin nanoforms and bulk forms on DSBs at 
basal levels by analysing the gamma-H2AX protein expres-
sion immunocytochemically.
Methodology
Blood sample collection and ethics
The current project involving the use of human periph-
eral lymphocytes has been granted ethical approval by 
Leeds East Ethics Committee (IRAS Reference No.:12/
YH/0464) and the University of Bradford’s Sub-Com-
mittee for Ethics in Research involving healthy Human 
Subjects (Reference No.: 0405/8). All peripheral blood 
samples were collected after informed consent from 
patients and healthy individuals. The research support 
and governance office of Bradford Teaching Hospitals 
NHS Foundation also agreed the research (REDA num-
ber 1202).
Informed consent
The blood samples from healthy individuals and 
MGUS patients used in the current study were col-
lected after obtaining informed consent from the 
participants and are listed in Tables 1 and 2, respec-
tively. Exclusion criteria for human subjects enrolled 
in the study were anaemia, blood diseases or major 
disorders.
Table 1  Healthy blood samples
No Age Ethnicity Gender Smoking 
history
Family history
1 48 Caucasian M No None
2 28 Caucasian M No None
3 27 African M Yes None
4 38 Caucasian M No None
5 60 Caucasian F No None
6 40 Arab M No None
7 45 Caucasian M Yes None
8 55 Caucasian M No None
9 35 Caucasian M Yes None
10 25 Caucasian M No None
11 44 Asian M Yes None
12 28 Caucasian M No None
13 23 Caucasian F No none
14 27 Caucasian M No None
15 33 Arab M Yes None
16 47 Asian M Yes None
17 28 Caucasian M No None
18 42 Asian M No None
19 48 Asian M No None
20 60 Asian M Yes None
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Preparation of myricetin bulk forms and nanoforms, 
concentration, solubility, and zeta potential 
of nanoparticles
Myricetin powder (˃ 96% purity) was purchased from Fisher 
Scientific, UK. Suspensions of myricetin bulk forms and 
nanoforms were made in an excipient mixture (containing 7% 
(w/w) solid loads of myricetin in a medium comprising of 
hydroxypropyl methylcellulose (HPMC) (0.5% w/w), sodium 
lauryl sulphate (SLS) (0.1% w/w), ethanol (0.8% w/w), poly-
vinylpyrrolidone (PVP) K-30 (0.5% w/w) and purified water). 
The suspensions were transferred to an amber glass bottles 
and stored at 4 °C for the research duration. The mean particle 
sizes and zeta potential (ZP) of myricetin bulk and nano in the 
stock solutions were measured using a Zetasizer Nano ZS-90 
Model ZEN3600 (Malvern Instruments Ltd, UK) by photon 
correlation spectroscopy. The initial particle sizes of bulk and 
nano were 1737 and 161 nm, respectively and their ZP meas-
urement was less than 1% indicating their good stability. The 
suspensions were also sonicated for 10 min before each use to 
avoid sedimentation and control aggregation.
In vitro experimental design, preliminary 
treatment, and concentration range study 
in lymphocytes
TBHP is a known intracellular stress inducer hence; increase 
in ROS production was used as a factor to choose the opti-
mum concentration of TBHP for 0–60 min. The concentra-
tion dependent responses of TBHP are shown in Fig. 1a. 
TBHP has induced significant levels of ROS at each deter-
mined concentration after 60 min of treatment. However, at 
300 µM, its activity was at highest when compared to the 
untreated group.
Flavonoid compounds have this ability to cause adverse 
effects at slightly different concentrations; therefore, we 
used the safer concentrations with no significant genotoxic-
ity. Based on the dose–response studies, 10 µM for MYR B 
and 20 µM for MYR N were optimal doses with no cellular 
toxicity (Fig. 1b).
The optimal concentration of  H2O2 (50 µM) used through-
out the study as the positive control and for co-supplementa-
tion in the Comet assay was determined by the dose response 
Table 2  Brief information about 
patient samples
M male, F female, MGUS monoclonal gammopathy of unknown significance
No Age Ethnicity Gender Smoking 
history
Family history Medical condition
1 79 Caucasian M No None MGUS
2 80 Caucasian F No None MGUS
3 78 Caucasian M No None MGUS
4 56 Caucasian F Yes Leukaemia and brain Tumour MGUS
5 77 Caucasian M No None MGUS
6 75 Caucasian M No None MGUS
7 80 Caucasian M No Cancer Positive MGUS
8 81 Caucasian F No Bowel and stomach MGUS
9 63 Caucasian M Yes None MGUS
10 55 Caucasian M No None MGUS
11 83 Caucasian M No None MGUS
12 63 Caucasian M Yes None MGUS
13 74 Caucasian M No None MGUS
14 63 caucasian F Yes Arthritis MGUS
15 66 Caucasian F No Breast cancer MGUS
16 52 caucasian M Yes None MGUS
17 83 Caucasian M No None MGUS
18 60 Asian F No None MGUS
19 75 Caucasian F No Mastectomy MGUS
20 69 Caucasian M No Stomach and lung MGUS
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(1c). Untreated lymphocytes were set as the negative control 
(NC). The optimal concentrations for TBHP and  H2O2 were 
used as positive controls (PC). After determining the opti-
mum doses for the test chemicals, PCs were simultaneously 
added to lymphocytes in suspension with either MYR B or 
MYR N in co-supplementation studies.
Confounding factors
The potential effects of the confounder such as smoking, 
age, ethnicity, and gender on results were analysed using 
the Comet assay. However, myricetin had no significantly 
different effect on any of these factors (Table 3).
MTT assay
The cytotoxicity of chemicals was determined by 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide (MTT) dye absorbance. Isolated lymphocytes  (104) 
were maintained in complete medium overnight in 96-well 
plates followed by treatment the next day. After the expo-
sure time (1 and 24 h) was over, 10 µl of MTT dye (Fisher 
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Fig. 1  a Average of three independent experiments showing, change 
in intracellular ROS after treatment with different concentrations of 
TBHP in healthy lymphocytes. All groups were compared against 
the untreated group. ***P < 0.001, *P = 0.02. Results are expressed 
as mean ± SE. b Concentration dependent responses of MYR B 
and MYR N in healthy lymphocytes showing mean OTM. All data 
have been expressed as mean ± standard errors (SE) of experiments 
in healthy individuals, measuring 100 cells each. In  vitro treatment 
of healthy lymphocytes with different concentrations of MYR B and 
MYR N in the Comet assay has shown that MYR B (10  µM) and 
MYR N (20  µM) produced least levels of the DNA damage which 
was comparative with the negative control (NC). Therefore, these 
optimum concentrations have been used throughout the study. Other 
treatment groups included, excipient mixture (EM) (0.1%) and PC 
 (H2O2 50 µM). The stars indicate significant difference between NC 
and various treatment groups (P < 0.05 significantly different), ns 
indicates not significant, ***P < 0.001, *P < 0.01. c Concentration-
dependent responses of  H2O2 in healthy lymphocytes showing mean 
OTM. All data have been expressed as mean ± standard errors (SE) 
of experiments in healthy individuals, measuring 100 cells each. 
In  vitro treatment of healthy lymphocytes with different concentra-
tions of  H2O2 in the Comet assay has shown that 50 µM of  H2O2 pro-
duced most significant levels of the DNA damage compared to the 
NC. Therefore, this optimum concentration has been used throughout 
the study as a PC (P < 0.05 was considered significantly different), ns 
indicates not significant, ***P < 0.001, *P < 0.01
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Scientific, UK) (5 mg/ml) was added to each well and incu-
bated for another 4 h at 37 °C in the dark. After this, medium 
was aspirated and 200 µl of DMSO (Fisher Scientific, UK) 
was added to each treatment and absorbance was read at 
570 nm.
The Comet assay for determination of DNA damage
Lymphocytes were treated with MYR B (10 µM) and MYR 
N (20 µM) in combination with  H2O2 (50 µM) for 1 h. The 
cell suspension was centrifuged at 3000 rpm (1000 g). The 
supernatant was removed and the pelleted cells were sub-
jected for the Comet assay as previously defined with some 
changes (Singh et al. 1988; Tice et al. 2000; OECD 2016; 
Anderson et al. 2014; Azqueta and Dusinska 2015).
Measurement of ROS accumulation in isolated 
lymphocytes
Isolated lymphocytes were grown in a 96-well plate over-
night. Cells were washed with phosphate buffer saline (PBS) 
prior to addition of various chemical treatments in PBS and 
incubated for 1 h at 37 °C in the presence of 5%  CO2. Once 
incubation was over, the cells were washed again with PBS 
following the loading of a fluorescent probe, DCFDA dye 
(Abcam, UK) into each well and incubated again for 45 min 
under the same conditions. Then dye was replaced by 100 µl 
of PBS and fluorescence was measured at 485/535 nm using 
Promega Glomax explorer version 2.4. Data were analysed 
using the Graph Pad Prism 7.02.
Assay of cellular enzyme and total thiol content
Reduced glutathione (GSH) levels and oxidised glutathione 
(GSSG) contents in experimental and normal lymphocytes 
were analysed using the GSH/GSSG Ratio Detection Assay 
Kit (Fluorometric—Green) (Abcam, UK) according to 
the manufacturer protocol. Briefly, isolated lymphocytes 
were harvested overnight in 6-well plate then treated with 
chemicals for 1 h. Cells were washed with cold PBS and re-
suspended in 100 µl of cold lysis buffer supplemented with 
10 µl of protease inhibitors then thoroughly mixed by pipet-
ting and centrifuged at 400g for 5 min to remove insoluble. 
The supernatant (sample) was collected and kept on ice for 
further use. 50 µl of each GSH and GSSG standards (kit 
components) were added to 96-well plates in duplicates. 
For GSH detection, 50 µl of the GSH assay mixture (GAM) 
(provided with the kit) was added to each GSH standard 
and sample. For GSSG detection, total GSH assay mixture 
(TGAM) was added to each GSSG standard and sample. 
Incubated for 60 min at room temperature in the dark and 
then fluorescence was measured at 490/520 nm using Pro-
mega Glumax explorer version 2.4. Data were analysed 
using Graph Pad Prism 7.02.
Determination of histone‑2AX (H2AX) 
phosphorylation (γ‑H2AX) levels using 
Immunocytochemistry
The method was based on that of Schmid et al. (2010) and 
previously followed in our lab (Laubenthal et al. 2012). A 
total of 100 cells per treatment were examined under the 
fluorescence microscope connected with a CCD camera 
(Nikon Digital Sight DS-SMC, Surrey, UK) for gamma-
H2AX foci expression, a marker of DNA double-strand 
breaks. Untreated cells were used as the negative control, 
whereas doxorubicin (50 µM) was used as the positive con-
trol. Each experiment was done in triplicate with both con-
trols included.
Statistical analysis
Results were presented as mean ± SE and differences 
between the groups were analysed by one-way and two-way 
analysis of variance (ANOVA) using Graph Pad prism 7 
software. Values of p < 0.05 were considered significantly 
different.
Table 3  The effect of confounding factors in healthy individuals and MGUS patients using OTM
Subject Treatment group Smoker Non-smoker Asian Caucasian Male Female Young Old
OTM OTM OTM OTM OTM OTM OTM OTM
Healthy individuals NC 1.1 0.7 0.7 0.7 1.2 0.8 2.7 4.1
PC  (H2O2 50 µM) 8.9 10.7 11.8 8.9 8.1 13.5 6.7 10.3
MYR B (10 µM) 2.0 1.49 1.1 2.0 1.5 1.3 3.1 6.0
MYR N (20 µM) 1.5 0.8 1.4 0.89 2.0 1.2 1.6 3.05
MGUS patients NC 3.6 2.8 4.0 2.5 2.2 2.6 3.5 3.2
PC  (H2O2 50 µM) 9.0 8.7 15.5 6.2 6.4 5.4 9.5 11.9
MYR B (10 µM) 2.5 3.4 6.9 3.8 2.6 3.3 3.9462 4.5
MYR N (20 µM) 2.3 1.7 4 2.9 1.0 1.8 2.1384 3.1
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Results
Cytotoxicity of chemicals in lymphocytes
Cytotoxicity of test chemicals was determined by cultur-
ing lymphocytes from healthy individuals and MGUS 
patients and measuring the mean absorbance at 1 and 
24 h using the MTT dye. Results from the MTT assay 
showed that the test chemicals used in this study exhib-
ited non-significant level of cytotoxicity (which was 
approximately 5% lower compared to the untreated cells) 
occurred only after 24 h treatment, for all the treatment 
groups assessed in lymphocytes from both healthy and 
patient group (Fig. 2a, b).
Effect of MYR N & B on hydrogen peroxide 
 (H2O2)‑induced DNA damage in lymphocytes 
from healthy vs patient group using the Comet 
assay
In-vitro treatment of lymphocytes from healthy individuals 
and patients with MYR B (10 µM) and MYR N (20 µM), 
co-supplemented with 50 µM  H2O2, resulted in signifi-
cant reduction of DNA damage when compared to the 
PC (50 µM  H2O2) alone. MYR N and NC show the same 
level of DNA damage in healthy lymphocytes both in %tail 
DNA and Olive tail moment (OTM). The  H2O2-induced 
DNA damage was significantly reduced by MYR B and 
MYR N in both groups, whereas MYR N was more effec-
tive in healthy group when compared to the PC (Fig. 3a, 
b), giving the value almost similar to the untreated group.
Antioxidant effects of myricetin
The study used a cell permeant reagent 2′,7′-dichlorofluo-
rescin diacetate (DCFDA) that measures total intracellular 
ROS activity and levels. Once diffused into the cells, cel-
lular esterases deacetylate DCFDA as a non-fluorescent 
form which is later oxidized to a highly fluorescent com-
pound, 2′,7′-dichlorofluorescein (DCF), by interacting 
with ROS and easily detected by fluorescence spectros-
copy. The effect of MYR B and MYR N on basal ROS 
was determined in lymphocytes from the healthy group 
and pre-cancerous patients. Results showed that MYR N 
has significantly reduced the ROS levels in lymphocytes 
from both groups.
TBHP‑induced oxidative injury in lymphocytes: 
protection by myricetin
Exposure of healthy and patient lymphocytes to TBHP 
alone induced a significant increase in ROS levels by 40%. 
However, upon treatment with MYR B and MYR N, a sig-
nificant attenuation of TBHP-induced ROS was observed 
in lymphocytes from both groups (Fig. 4a, b).
Activity of intracellular antioxidant enzyme, GSH, 
and change in GSH/GSSG ratio
The effects of MYR B and MYR N on the basal levels of 
GSH were assessed by treating lymphocytes from healthy 
and patient group with both forms of myricetin alone. 
MYR B and MYR N have shown a trend to increase the 
basal levels of GSH/GSSG ratio in lymphocytes from pre-
cancerous patients, but levels are not significantly differ-
ent. Hence, myricetin does not show any substantial effect 
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Fig. 2  % Cytotoxicity in 2 × 104 cells of various test treatments in 
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considered as cytotoxic. Error bars show mean values ± SE, n = 3. 
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on GSH levels in lymphocytes from healthy individuals 
and in those from pre-cancerous patients (Fig. 5a, b).
Effect of myricetin on DSB formation in lymphocytes 
at basal levels
DSBs in the nuclei of lymphocyte cells were immunocyto-
chemically stained using the γH2AX protein, and γH2AX 
foci inside each nucleus were counted in 100 cells each. 
One DSB represented one γH2AX focus. Results showed 
that myricetin does not cause DSBs in healthy lympho-
cytes (Fig. 6a, b). Compared to the number of foci gener-
ated in the control, both forms of myricetin (MYR B and 
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Fig. 3  a Mean % tail DNA showing effect of MYR N & B on 
 H2O2-induced DNA damage in lymphocyte taken from healthy indi-
viduals and pre-cancerous patients. Figure shows four groups of 
treatments including the negative control, excipient mixture, positive 
control, MYR B (10 µM) co-supplemented with  H2O2 and MYR N 
(20 µM) co-supplemented with  H2O2. All treatments were compared 
against the PC. The mean control values for the % tail DNA of NC 
and PC group for healthy individuals and patients were 9, 22 and 18, 
29, respectively, measuring 100 cells each per experiment. Aster-
isk shows significant difference between the groups. The horizontal 
lines on top of the graph show the significance difference the positive 
control and the treatment groups. (For healthy groups **P < 0.009, 
***P < 0.005. For patient groups ****P < 0.001, *** P< 0.003). 
b Mean OTM showing the effect of MYR B & N on  H2O2-induced 
DNA damage in lymphocytes from healthy volunteers and pre-can-
cerous patients. Figure shows four groups of treatments including the 
negative control, positive control, MYR B (10 µM) co-supplemented 
with  H2O2 and MYR N (20  µM) co-supplemented with  H2O2. All 
treatment groups were compared to the PC group. The mean NC 
values for the OTM of healthy and patient groups were 0.9 and 4.5, 
respectively. The mean maximum values of the PC of healthy and 
patient groups were 5 and 8, respectively. The horizontal lines on 
top of the graph show the significance difference between the posi-
tive control and the treatment groups. (***P < 0.001, ***P < 0.007 
shown on healthy groups and ***P < 0.002, ***P < 0.001 for patients 
groups)
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Fig. 4  a Average of 3 independent experiments showing, change in 
intracellular ROS before and after treatment with TBHP in healthy 
lymphocyte. The horizontal lines show the significant difference 
between the groups. ***P < 0.001, ns not significant. Six treat-
ment groups included an untreated group (NC), MYR B (10  µM), 
MYR N (20  µM), TBHP ((300  µM) as PC, TBHP + MYR B, and 
TBHP + MYR N. b Average of 3 independent experiments showing, 
change in intracellular ROS before and after treatment with TBHP 
in lymphocyte from pre-cancerous patients. The horizontal lines 
show the significant difference between the groups. Ns not signifi-
cant, ***P < 0.001. Six treatment groups included an untreated group 
(NC), MYR B (10 µM), MYR N (20 µM), TBHP ((300 µM) as PC, 
TBHP + MYR B, and TBHP + MYR N
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MYR N) have not shown any significant increase in foci 
formation. However, as shown in Fig. 6b, an increased 
number of γH2AX foci formation was observed after 
treatment of the healthy lymphocytes with doxorubicin, 
a known strand break inducer (PC) (p < 0.001). Foci for-
mation was observed at basal levels in untreated group 
from pre-cancerous patients and this incidence of the foci 
formation was significantly increased (p < 0.001) after 
doxorubicin treatments. Upon treatment with MYR B 
(10 µM) and MYR N (20 µM) forms in lymphocytes from 
pre-cancerous patients, no significant effect was observed 
in γH2AX foci formation compared to the untreated group. 
This suggests that myricetin does not induce DSBs in 
healthy lymphocytes at basal levels and could potentially 
provide protection against DSBs formation in lymphocytes 
from pre-cancerous patients at basal levels.
Discussion
In this study, we determined the effects of myricetin 
against  H2O2-induced DNA damage by simultaneously 
exposing the cells to  H2O2 (50 µM) in the presence or 
absence of MYR B or MYR N. The Comet assay results 
have shown the protective effect of myricetin bulk and 
nanoparticles (NPs) against  H2O2-induced ROS-related 
oxidative damage in the lymphocytes of healthy individu-
als and pre-cancerous MGUS patients. The basal DNA 
damage was significantly inhibited when compared to 
the positive control (Fig. 3a, b). Both forms of myricetin 
have shown inhibitory effects, whereas MYR N was more 
effective in causing the reduction in DNA damage, may 
be due to its enhanced physio-chemical characteristics 
(p < 0.001). The potential explanation for this could be that 
NPs due to their minute size can easily reach the nucleus 
through diffusion across the nuclear membrane or trans-
portation via the nuclear pores and gain direct interaction 
with the DNA (Magdolenova et al. 2012, 2014). This could 
be further investigated and confirmed by studying the sub-
cellular distribution of these particles using transmission 
electron microscopy (TEM).
ROS play a crucial role in stimulating DNA strand 
breaks formation and causing oxidative stress (Tanaka 
et al. 2007). Accumulation of the DNA damage induced 
by ROS can lead to various deleterious processes includ-
ing the stimulation of neoplasms production and eventu-
ally tumour development (Tanaka et al. 2007; Vilenchik 
and Knudson 2003). To evaluate the antioxidant poten-
tial of myricetin, we investigated its antioxidant effects in 
lymphocytes from healthy individuals and pre-cancerous 
MGUS patients by measuring intracellular ROS contents. 
The basal levels of ROS and the effect of myricetin against 
TBHP-induced ROS were evaluated. Results have dem-
onstrated that myricetin has reduced the basal damage in 
lymphocytes from both the investigated groups as well 
as the insults introduced by TBHP treatment (Fig. 4a, b). 
Both forms of myricetin have shown strong antioxidant 
defence by scavenging the free radicals caused by ROS 
and by reducing their levels intracellularly. However, 
when two forms were compared, MYR N (20 µM) demon-
strated more protective effects than MYR B (10 µM). Our 
results are consistent with previous studies (Wang et al. 
2010; Kang et al. 2010). Inhibition of ROS may prevent 
its accumulation, also the interaction of floating radicals 
with cellular contents and DNA fragmentation, avoiding 
DNA lesions and strand breaks. Hence, myricetin shows 
anti-mutagenic and anti-carcinogenic properties by pre-
venting mutations at non-genotoxic concentrations used 
for both forms of myricetin. These results are consistent 
with previous studies conducted on various cells lines 
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Fig. 5  Levels of different forms of GSH in healthy lymphocyte (a) 
and those from pre-cancerous patients (b). Cells lysed to the concen-
tration of 1 × 105 cells/ml. Various treatment groups included the NC 
(untreated), EX, MYR B (10 µM), MYR N (20 µM),  H2O2 (50 µM) 
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using myricetin. It has been previously shown that myri-
cetin protects cells from  H2O2 damage by inhibiting ROS 
production and by stimulating the antioxidant enzymes. 
It restored the function of antioxidant defence enzymes 
such as catalase (CAT), superoxide dismutase (SOD), and 
glutathione peroxidase (GPx) which was reduced by  H2O2 
treatment (Wang et al. 2010).
Although we used the fluorescent probe DCFDA to detect 
ROS levels, the formamido pyrimidine glycosylase (FPG) 
protein could also be considered to assess oxidative DNA 
damage using the Comet assay (Müller et al. 2013).
Furthermore, this study also investigated the effect of 
myricetin on intracellular glutathione levels. In healthy 
cells, the total glutathione pool is mostly in the reduced 
form (GSH), a key tissue antioxidant that presents first line 
of defense against ROS. However, when cells are exposed 
to increased levels of oxidative stress, oxidized glutathione 
(GSSG) starts gathering and the ratio of GSSG to GSH 
rises. Hence, a bigger ratio of GSSG-to-GSH is an indica-
tion of oxidative stress (Roy and Sil 2012). Our results 
have demonstrated no significant effect on GSH levels 
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Fig. 6  a γH2AX phosphorylation in lymphocytes from healthy indi-
viduals and pre-cancerous patients presented in untreated cells (NC) 
and treated with doxorubicin (50 μM), MYR B (10 Μm), and MYR 
N (20 μM). a Merged Dapi and gamma-H2AX stains in blood lym-
phocytes from healthy individuals and pre-cancerous patients. Num-
ber of phosphorylated H2AX-foci corresponds with DSBs. b γH2AX 
foci induction in lymphocytes with different treatment groups. Data 
were analysed by two-way ANOVA followed by multiple comparison 
test for significant differences compared to the untreated control for 
each group (***p < 0.001, ns not significant)
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after treatment with MYR B and MYR N in lymphocytes 
from healthy and MGUS patient groups (Fig. 5a, b).
Gamma-H2AX is used as an effective biomarker of 
DSBs. An accumulating body of evidence suggests that 
the crucial role of γH2AX phosphorylation for nuclear 
foci formation at DBS sites and stimulation of DNA repair 
(Rogakou et al. 1998; Podhorecka et al. 2010). There exists 
a one-to-one correspondence between DSBs and gamma-
H2AX foci; hence, DSBs can be easily visualised immu-
nocytochemically (Rogakou et al. 1999). The number of 
foci, therefore, could be used as a relative parameter to 
estimate DNA damage and repair. To evaluate the effect 
of myricetin on DSBs formation in lymphocytes from 
healthy individuals and those from pre-cancerous MGUS 
patients, we quantified γH2AX foci intensity using immu-
nofluorescence. Our results have shown that myricetin 
does not induce DSBs formation in healthy lymphocyte 
and those from the pre-cancerous patients at basal levels 
(Fig. 6a, b) which is consistent with our previous results 
from the Comet assay where no significant DNA damage 
was caused upon exposure to MYR B (10 µM) and MYR 
N (20 µM). However, a trend to lower an overall intensity 
of γH2AX foci was observed in the lymphocytes from pre-
cancerous MGUS patients treated with MYR B and MYR 
N when compared to the untreated group. This marks the 
current study as the first one to demonstrate the effect of 
MYR B (10 µM) and MYR N (20 µM) on DSBs develop-
ment in lymphocytes from healthy individuals and those 
from pre-cancerous MGUS patients at basal levels.
In conclusion, this work demonstrates for the first time 
(to our knowledge) that myricetin bulk and nano at selec-
tive non-genotoxic concentrations protect the lymphocytes 
(from healthy individuals and pre-cancerous patients) from 
damaging effects of TBHP and  H2O2 primarily by inhibiting 
ROS-induced oxidative stress. Besides this, MYR B (10 µM) 
and MYR N (20 µM) do not induce formation of DSBs in 
lymphocytes from healthy individuals and pre-cancerous 
MGUS patients at basal levels and could possibly protect the 
lymphocytes from extensive cell damage by inhibiting DSBs 
formation and ultimately help in cell survival and DNA 
damage repair. DNA repair capacity of lymphocytes after 
treatment with myricetin could possibly be studied using 
the Comet assay simply by assessing the damage at different 
time periods (Collins 2004). The overall results have dem-
onstrated that MYR N (20 µM) has shown better antioxidant 
and genoprotective effects against the oxidative damage in 
lymphocytes from healthy individuals and pre-cancerous 
MGUS patients when compared to MYR B (10 µM).
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